SCHEMBL4354182

SCHEMBL4354182

Cc1ccccc1CNC(=S)Nc1ccc(F)c(F)c1O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 5/20 0.51
LMNA P02545 4/20 0.51
MAPT P10636 2/20 0.51
KMT2A Q03164 6/20 0.49
MEN1 O00255 5/20 0.49
POLB P06746 3/20 0.49
HPGD P15428 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
HTT P42858 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 3/20 0.46
PKM P14618 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12846889 0.88 MEN1 (0.56) ALOX12LMNAMAPTKMT2AMEN1
SCHEMBL4349842 0.86 KMT2A (0.56) ALOX12LMNAMAPTKMT2AMEN1
SCHEMBL4351491 0.81 ALOX12 (0.59) ALOX12MAPTKMT2AMEN1POLB
SCHEMBL4345595 0.79 MEN1 (0.46) ALOX12LMNAMAPTKMT2AMEN1
SCHEMBL4345586 0.79 LMNA (0.51) ALOX12LMNAMAPTKMT2AMEN1
SCHEMBL4351417 0.78 MEN1 (0.70) ALOX12LMNAMAPTKMT2AMEN1
SCHEMBL4349820 0.76 ALOX12 (0.56) ALOX12LMNAMAPTKMT2AMEN1
SCHEMBL4347019 0.76 ALOX12 (0.59) ALOX12LMNAMAPTKMT2AMEN1
SCHEMBL4358617 0.74 MAPT (0.52) ALOX12LMNAMAPTKMT2AMEN1
SCHEMBL4351089 0.74 LMNA (0.64) ALOX12LMNAMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 ALOX12 1546/4885LMNA 3160/4885MAPT 4439/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 ALOX12 1994/4885LMNA 3661/4885MAPT 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.